key: cord-0785366-jtsla68g authors: Kanitakis, Jean; Lesort, Cécile; Danset, Marie; Jullien, Denis title: CHILBLAIN-LIKE ACRAL LESIONS DURING THE COVID-19 PANDEMIC (“COVID TOES”): HISTOLOGIC, IMMUNOFLUORESCENCE AND IMMUNOHISTOCHEMICAL STUDY OF 17 CASES date: 2020-06-02 journal: J Am Acad Dermatol DOI: 10.1016/j.jaad.2020.05.145 sha: a395c42f7f83bdd3ccf07e5b8b5e710b650d69fd doc_id: 785366 cord_uid: jtsla68g Abstract Background During the COVID-19 pandemic, several acral chilblain-like skin lesions (CBLL) were observed in young patients with suspected, but mostly unconfirmed, infection with SARS-CoV-2. The histopathological aspect of these lesions is as yet poorly known. Objective To investigate the pathologic features of CBLL. Methods Biopsies were obtained from 17 cases of CBLL during the COVID-19 pandemic in France and were studied by routine histological examination, immunohistochemistry and direct immunofluorescence (DIF). The patients had suspected but unconfirmed infection with SARS-CoV-2 (negative nasopharyngeal PCR test and serological tests). Results CBLL showed many features with those reported in idiopathic (IC) and auto-immune related chilblains (AC), including epidermal necrotic keratinocytes, dermal edema, perivascular and perieccrine sweat gland lymphocytic (predominantly CD3/CD4+) inflammation and frequent vascular changes (endothelialitis, microthromboses, fibrin deposition, immunoreactant deposits on vessels). Conclusions CBLL show similar histopathologic features with IC and AC, with a rather high rate of vascular changes and DIF positivity. The role of SARS-CoV-2 in the development of these puzzling lesions remains to be elucidated. fever, cough and pneumonia, that may be severe and lethal. The disease is due to a new zoonotic-transmitted coronavirus named Severe Acute Respiratory Syndrom Coronavirus 2 (SARS-CoV-2). This was initially isolated in Wuhan (China) in December 2019 but has since spread worldwide, causing a pandemic disease with hundreds of thousand fatalities up till now. 1,2 COVID-19 is a multisystemic disease affecting several systems in addition to the respiratory one, such as the gastrointestinal tract 3 and the central nervous system. 4 Several skin manifestations have been reported in patients with confirmed or suspected COVID-19, including morbilliform rashes, a papulovesicular varicella-like eruption, urticaria, livedoid rashes and petechial/purpuric lesions (5) (6) (7) (8) (9) . In addition, several puzzling cases of chilblainlike lesions (CBLL) of the extremities (mainly the toes) were recorded in several countries from Europe and the Middle East contemporarily with the COVID-19 spread. [10] [11] [12] [13] [14] [15] These lesions accounted for 19-38% of all cutaneous lesions associated with known or strongly suspected COVID-19 in two recent studies from France 10 and Spain; 13 they were observed in young patients with no, or only mild, systemic symptoms, and appeared rather late in the course of the (suspected) infection. These lesions have been termed "COVID-toes", 16 even though their causal relationship with SARS-CoV-2 has not been convincingly proven. Among 63 such Italian cases, a swab test was positive in merely 3.2% of patients. 11 Another report on CBLL included two patients tested COVID-19 positive but another patient was negative by PCR and rapid antibody test. 15 The pathological features of CBLL in this setting have not been extensively studied. Up till now, a histopathological study of CBLL has been published in only one COVID-19 confirmed case 17 and in four possible but unconfirmed COVID-19+ cases. 10, 16 We performed a histopathologic, immunohistochemical and immunofluorescence study of a series of 17 CBLL in order to get further insight into their pathogenesis, and especially to assess whether these lesions have diagnostic microscopic features allowing their differentiation from clinically similar lesions, such as idiopathic chilblains and those associated with autoimmune disorders (namely lupus erythematosus). This case series study included 17 patients (11 men/7 women, mean age 32 years, range: 15-63) who were referred to our Dermatology department in April 2020 for cutaneous redviolaceous, edematous, rarely necrotic, CBLL localized on the toes (n:9), the feet (heel, sole, n:6) and/or the fingers (n :2). Among these patients, five mentioned recent non-specific general symptoms preceding the onset of cutaneous lesions (cough, fever or weakness) and 5, inset) . In the 3 remaining cases DIF was either negative or showed nonspecific findings (such as C3 microgranular deposits at the dermal-epidermal junction or IgM deposits on colloid bodies of the papillary dermis). Although the clinical appearance of the CBLL we investigated in this study is very similar, if not identical, to that of both IC and AC, these lesions are distinct from an etiological point of view. Indeed, the CBLL appeared during March 2020 (which was in France one of the warmest recorded ever), a fact that is against the role of cold and humid weather, as is the case for IC. Furthermore, the autoimmunity workup performed in our patients (namely for antinuclear antibodies) ruled out an underlying autoimmune disease, such as lupus erythematosus, which may be associated with pernio-like lesions ('lupus pernio'). The term 'COVID toes' reflects the particular circumstances under which the outbreak of CBLL was recorded, although the term 'COVID chilblains' (by analogy to idiopathic or autoimmune chilblains) would be more correct. Our study, which concerns so far the largest series of pathologically-studied CBLL, show that these lesions share several pathological features with both idiopathic (IC) and autoimmune-associated (AC) chilblains. Indeed, despite some claimed differences, IC and AC are difficult to separate pathologically from each other. Papillary edema and peri-eccrine sweat gland localization of the dermal infiltrate have been claimed to favor the diagnosis of IC over AC, [13] [14] [15] although an earlier study had not found such differences. 16 Conversely, basal cell layer vacuolization and interface changes were claimed to be more common in AC vs IC, 20,21 but the differences are not discriminating from a statistical point of view. More recently it was reported that the presence of abundant dermal mucin and interstitial fibrin were associated with lupus erythematosus, but that the number and distribution of CD123+ pDC and CD30+ lymphocytes had no discriminatory role. 22 Our results show that the CBLL exhibit, to various degrees, the most common pathological features of IC and AC, including necrotic epidermal keratinocytes, papillary edema, dense perivascular and peri-eccrine sweat gland inflammation, predominance of CD3+/CD4+ T-cells, and presence of CD303+ pDC and CD30+ activated cells in the dermal infiltrate. Rarer but remarkable findings include the presence of vascular microthromboses and fibrin deposition in the wall of dermal venules. The presence of eosinophils in the dermal infiltrate has not been, as far as we know, reported in IC or AC [18] [19] [20] [21] [22] and is remarkable, even though eosinophils were found in small numbers and in a minority of our cases. Similarly, the high rate of positive DIF showing vascular deposits of IgM, IgA and/or C3 is an original finding. Indeed, DIF was negative in a case of COVID-19 associated chilblain, 17 showed a lupus band test in 21% of cases of AC 19 and showed non-specific findings in cases of IC associated with myelomonocytic leukemia; 23 these studies did not mention specific vascular deposits. The pathogenesis of these CBLL remains unclear. Our findings, namely the deposits of A Novel Coronavirus from Patients with Pneumonia in China Novel Coronavirus Pneumonia Emergency Response Epidemiology Team SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant Neurologic Features in Severe SARS-CoV-2 Infection Cutaneous manifestations of COVID-19: Report of three cases and a review of literature Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients Petechial Skin Rash Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Dermatologic Manifestation of COVID-19: Transient Livedo Reticularis COVID-19 can present with a rash and be mistaken for dengue Chilblains are a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases A case of COVID-19 presenting in clinical picture resembling chilblains disease. First report from the middle East Chilblain-like lesions on feet and hands during the COVID-19 Pandemic A case of pernio-like lesions U4ppUAnhlibg/edit?fbclid=IwAR0WXLm8PeDFIbU46EVRIZdveMVhDA3epQXQfCOZ57SWzK4 COVID-19) infection-induced chilblains: A case report with histopathologic findings. JAAD Case Rep A histologic and immunohistochemical study of chilblains Clinical and histopathologic features and immunologic variables in patients with severe chilblains. A study of the relationship to lupus erythematosus Perniosis: clinical and histopathological analysis Idiopathic perniosis and its mimics: a clinical and histological study of 38 cases Comparative analysis of chilblain lupus erythematosus and idiopathic perniosis: histopathologic features and immunohistochemistry for CD123 and CD30 Idiopathic chilblains in myelomonocytic leukemia: not a simple association Anticoagulant treatment is associated with decreased mortality in severe coronooavirus disease 2019 patients with coagulopathy Endothelial cell infection and endotheliitis in COVID-19 Digitate Papulosquamous Eruption Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection We thank our colleagues who referred patients to us, and Dr Georgia Karayannopoulou (AHEPA Hospital, Thessaloniki, Greece) for fruitful discussions.